The Federal Reserve announced earlier this month that it will launch a real-time payment service called “FedNow” sometime in the…

On April 2, 2019, outgoing U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb released the Proposed Regulatory Framework for Modifications to…

As any astute beer shopper can attest, alcohol retailers’ shelves these days are loaded with a wide array of innovative…

Americans are concerned about their ability to save for retirement. We hear this every day from our friends and family,…

Stigler banker Christopher Jordan summed up the impact federal regulations have had on his business with a simple example. “If…

Skepticism of government regulation is one of the main tenets of economic conservatism, and for the most part is it…

In 2018, the California Supreme Court announced a new test for determining whether a worker is an employee or an…

In this inaugural episode of the Regulatory Transparency Project’s Explainer podcast series, James Coleman and Ann Carlson discuss the merits…

Title III of the Americans with Disabilities Act requires public accommodations be accessible to the disabled community. Since its enactment…

The strictures of the Appointments Clause are receiving renewed attention in the courts, including the Supreme Court. A year ago,…

The Federal Reserve plays a central role in the nation’s payment systems. Reserve banks keep currency in circulation to meet…

On June 18, 2019, the Federalist Society’s Article I Initiative and Regulatory Transparency Project hosted a panel on “Agency Rulemaking:…

The authors of this paper argue that the modern consumer welfare standard is an objective, consistent, reliable, and appropriate framework for good antitrust law and enforcement.

The authors of this paper argue that outdated consent decrees should be ended to take full advantage of modern technologies for the distribution of music.

In this paper, Gregory Jacob, Michael Lotito, and Tammy McCutchen argue that Department of Labor regulations have failed to keep pace with rapid technological change and that updating these rules could benefit both workers and employers.

The authors of this paper explore the FTC’s recent antitrust actions in pharmaceutical patent litigation and argue that, while well-intentioned, these actions hamper medical innovation and constitute a net loss for consumers.

The authors of this paper introduce and identify the ‘regulatory thicket’ — the compliance burdens caused by the accumulation of individual federal, state, and local regulations — and its effect on the ability of entrepreneurs and small business owners to pursue the American Dream. The authors explore this systemic issue and propose guidelines to trim the ‘regulatory thicket.’

The authors of this paper discuss the patent system’s integral role in a flourishing innovation economy and argue that recent actions in this system by antitrust authorities have had “a deleterious effect on high-tech innovation in the spaces of standards and patent licensing,” and on innovation in general.